Acta Haematologica · 2008 · 38 citations · 26 references
MedicineHematologyPathologyHematopathologyHemostasisImmunopathologyCoagulation AbnormalitiesCoagulation DisordersFibrin FormationMultiple MyelomaThrombin GenerationThrombosisDisorders Of FibrinolysisFibrin Clot FormationFibrinogen InfluenceFibrinogen InteractionMultiple Myeloma TherapyProthrombin ActivationThrombin TimeThrombin-fibrinogen Interactions
Abnormal coagulation properties indicative of a dysfibrinogen were found in the plasma of a 72-year-old male with multiple myeloma (IgGkappa, stage IIIA). The patient had high paraprotein concentration (85.75 g/l) and prolonged thrombin time (76.8 s), activated partial thromboplastin time (39.5 s), prothrombin time (23.5 s) and reptilase time (72.0 s). The fibrinogen level was increased. The fibrin polymerization induced by both thrombin and reptilase was impaired. Scanning electron microscopy revealed abnormal clot morphology. After six months of treatment, the paraprotein level decreased (19.48 g/l) and coagulation normalized as well as fibrin polymerization and fibrin clot morphology. It was found that the paraprotein interacts with the gamma-chain of fibrinogen. Acquired dysfibrinogenemia associated with multiple myeloma was diagnosed in the 72-year-old patient.
26
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Dysfibrinogenemia Associated with Hepatoma
Harvey R. Gralnick, Harry Givelber, Emanuel Abrams · New England Journal of Medicine · 1978 · 103 citations
Medicine, Biochemistry, Pathology +17